» Articles » PMID: 33772077

Glutathione Ethyl Ester Reverses the Deleterious Effects of Fentanyl on Ventilation and Arterial Blood-gas Chemistry While Prolonging Fentanyl-induced Analgesia

Overview
Journal Sci Rep
Specialty Science
Date 2021 Mar 27
PMID 33772077
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

There is an urgent need to develop novel compounds that prevent the deleterious effects of opioids such as fentanyl on minute ventilation while, if possible, preserving the analgesic actions of the opioids. We report that L-glutathione ethyl ester (GSHee) may be such a novel compound. In this study, we measured tail flick latency (TFL), arterial blood gas (ABG) chemistry, Alveolar-arterial gradient, and ventilatory parameters by whole body plethysmography to determine the responses elicited by bolus injections of fentanyl (75 μg/kg, IV) in male adult Sprague-Dawley rats that had received a bolus injection of GSHee (100 μmol/kg, IV) 15 min previously. GSHee given alone had minimal effects on TFL, ABG chemistry and A-a gradient whereas it elicited changes in some ventilatory parameters such as an increase in breathing frequency. In vehicle-treated rats, fentanyl elicited (1) an increase in TFL, (2) decreases in pH, pO and sO and increases in pCO (all indicative of ventilatory depression), (3) an increase in Alveolar-arterial gradient (indicative of a mismatch in ventilation-perfusion in the lungs), and (4) changes in ventilatory parameters such as a reduction in tidal volume, that were indicative of pronounced ventilatory depression. In GSHee-pretreated rats, fentanyl elicited a more prolonged analgesia, relatively minor changes in ABG chemistry and Alveolar-arterial gradient, and a substantially milder depression of ventilation. GSHee may represent an effective member of a novel class of thiolester drugs that are able to prevent the ventilatory depressant effects elicited by powerful opioids such as fentanyl and their deleterious effects on gas-exchange in the lungs without compromising opioid analgesia.

Citing Articles

The epigenetic signatures of opioid addiction and physical dependence are prevented by D-cysteine ethyl ester and betaine.

McDonough J, Singhal N, Getsy P, Knies K, Knauss Z, Mueller D Front Pharmacol. 2024; 15:1416701.

PMID: 39281282 PMC: 11392886. DOI: 10.3389/fphar.2024.1416701.


The cell-permeant antioxidant D-thiol ester D-cysteine ethyl ester overcomes physical dependence to morphine in male Sprague Dawley rats.

Getsy P, Coffee G, Bates J, Parran T, Hoffer L, Baby S Front Pharmacol. 2024; 15:1444574.

PMID: 39253377 PMC: 11381264. DOI: 10.3389/fphar.2024.1444574.


Tropine exacerbates the ventilatory depressant actions of fentanyl in freely-moving rats.

Getsy P, May W, Young A, Baby S, Coffee G, Bates J Front Pharmacol. 2024; 15:1405461.

PMID: 38978984 PMC: 11228531. DOI: 10.3389/fphar.2024.1405461.


Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing.

Baby S, May W, Getsy P, Coffee G, Nakashe T, Bates J Front Pharmacol. 2024; 15:1381073.

PMID: 38698814 PMC: 11063261. DOI: 10.3389/fphar.2024.1381073.


The Reducing Agent Dithiothreitol Modulates the Ventilatory Responses That Occur in Freely Moving Rats during and following a Hypoxic-Hypercapnic Challenge.

Getsy P, Coffee G, May W, Baby S, Bates J, Lewis S Antioxidants (Basel). 2024; 13(4).

PMID: 38671945 PMC: 11047747. DOI: 10.3390/antiox13040498.


References
1.
Nelson L, Schwaner R . Transdermal fentanyl: pharmacology and toxicology. J Med Toxicol. 2009; 5(4):230-41. PMC: 3550407. DOI: 10.1007/BF03178274. View

2.
Johnston K . The potential for mu-opioid receptor agonists to be anti-emetic in humans: a review of clinical data. Acta Anaesthesiol Scand. 2009; 54(2):132-40. DOI: 10.1111/j.1399-6576.2009.02115.x. View

3.
Trescot A, Datta S, Lee M, Hansen H . Opioid pharmacology. Pain Physician. 2008; 11(2 Suppl):S133-53. View

4.
Hajiha M, DuBord M, Liu H, Horner R . Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo. J Physiol. 2009; 587(Pt 11):2677-92. PMC: 2714030. DOI: 10.1113/jphysiol.2009.171678. View

5.
Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell G . Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol. 1994; 45(2):330-4. View